Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell, 124, 783–801.

Baskin C R, Bielefeldt-Ohmann H, Tumpey T M, Sabourin P J, Long J P, García-Sastre A, Tolnay A E, Albrecht R, Pyles J A, Olson P H, Aicher L D, Rosenzweig E R, Murali-Krishna K, Clark E A, Kotur M S, Fornek J L, Proll S, Palermo R E, Sabourin C L, Katze M G. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proceedings of the National Academy of Sciences of the United States of America, 106, 3455–3460.

Dias A, Bouvier D, Crépin T, McCarthy A A, Hart D J, Baudin F, Cusack S, Ruigrok R W. 2009. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature, 458, 914–918.

Elshina E, Te Velthuis A J W. 2021. The influenza virus RNA polymerase as an innate immune agonist and antagonist. Cellular and Molecular Life Sciences, 78, 7237–7256.

Graef K M, Vreede F T, Lau Y F, McCall A W, Carr S M, Subbarao K, Fodor E. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. Journal of Virology, 84, 8433–8445.

Honda K, Taniguchi T. 2006. IRFs: Master regulators of signaling by toll-like receptors and cytosolic pattern-recognition receptors. Nature Reviews Immunology, 6, 644–658.

Hou F, Sun L, Zheng H, Skaug B, Jiang Q X, Chen Z J. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell, 146, 448–461.

Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T. 2010. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. The Journal of Biological Chemistry, 285, 32064–32074.

Jiao P, Song Y, Huang J, Xiang C, Cui J, Wu S, Qu N, Wang N, Ouyang G, Liao M. 2018. H7N9 avian influenza virus is efficiently transmissible and induces an antibody response in Chickens. Frontiers in Immunology, 9, 789.

Jiao P, Tian G, Li Y, Deng G, Jiang Y, Liu C, Liu W, Bu Z, Kawaoka Y, Chen H. 2008. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. Journal of Virology, 82, 1146–1154.

Katze M G, Fornek J L, Palermo R E, Walters K A, Korth M J. 2008. Innate immune modulation by RNA viruses: Emerging insights from functional genomics. Nature Reviews Immunology, 8, 644–654.

Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii K J, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology, 6, 981–988.

Li N, Hong T, Li R, Wang Y, Guo M, Cao Z, Cai Y, Liu S, Chai T, Wei L. 2016. Cherry valley duck’s mitochondrial antiviral-signaling protein-mediated signaling pathway and antiviral activity research. Frontiers in Immunology, 7, 377.

Liniger M, Summerfield A, Zimmer G, McCullough K C, Ruggli N. 2012. Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2. Journal of Virology, 86, 705–717.

Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature, 437, 1167–1172.

Mibayashi M, Martínez-Sobrido L, Loo Y M, Cárdenas W B, Gale Jr M, García-Sastre A. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. Journal of Virology, 81, 514–524.

Moore CB, Ting JP. 2008. Regulation of mitochondrial antiviral signaling pathways. Immunity, 28, 735-739.

Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T. 2007. IFN beta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiology, 9, 930–938.

Patel D, Schultz L W, Umland T C. 2013. Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins. Virus Research, 172, 75–80.

Pichlmair A, Schulz O, Tan C P, Näslund T I, Liljeström P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5´-phosphates. Science, 314, 997–1001.

Qian W, Wei X, Guo K, Li Y, Lin X, Zou Z, Zhou H, Jin M. 2017. The c-terminal effector domain of non-structural protein 1 of influenza a virus blocks ifn-β production by targeting TNF receptor associated factor 3. Frontiers in Immunology, 8, 779.

Reich S, Guilligay D, Pflug A, Malet H, Berger I, Crépin T, Hart D, Lunardi T, Nanao M, Ruigrok R W, Cusack S. 2014. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature, 516, 361–366.

Reikine S, Nguyen J B, Modis Y. 2014. Pattern recognition and signaling mechanisms of RIG-I and MDA5. Frontiers in Immunology, 5, 342.

Santhakumar D, Rubbenstroth D, Martinez-Sobrido L, Munir M. 2017. Avian interferons and their antiviral effectors. Frontiers in Immunology, 8, 49.

Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity, 13, 539–548.

Schulz K S, Mossman K L. 2016. Viral evasion strategies in type I IFN signaling - a summary of recent developments. Frontiers in Immunology, 7, 498.

Seth R B, Sun L, Ea C K, Chen Z J. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell, 122, 669–682.

Severin C, Rocha de Moura T, Liu Y, Li K, Zheng X, Luo M. 2016. The cap-binding site of influenza virus protein PB2 as a drug target. Acta Crystallographica Section D (Structural Biology), 72, 245–253.

Sun H, Jiao P, Jia B, Xu C, Wei L, Shan F, Luo K, Xin C, Zhang K, Liao M. 2011. Pathogenicity in quails and mice of H5N1 highly pathogenic avian influenza viruses isolated from ducks. Veterinary Microbiology, 152, 258–265.

Varga Z T, Ramos I, Hai R, Schmolke M, García-Sastre A, Fernandez-Sesma A, Palese P. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathogens, 7, e1002067.

Te Velthuis A J, Fodor E. 2016. Influenza virus RNA polymerase: Insights into the mechanisms of viral RNA synthesis. Nature Review Microbiology, 14, 479–493.

Wei L, Cui J, Song Y, Zhang S, Han F, Yuan R, Gong L, Jiao P, Liao M. 2014. Duck MDA5 functions in innate immunity against H5N1 highly pathogenic avian influenza virus infections. Veterinary Research, 45, 66.

Weis S, Te Velthuis A J W. 2021. Influenza virus RNA synthesis and the innate immune response. Viruses, 13, 780.

Xu L G, Wang Y Y, Han K J, Li L Y, Zhai Z, Shu H B. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Molecular Cell, 19, 727–740.

Yi C, Zhao Z, Wang S, Sun X, Zhang D, Sun X, Zhang A, Jin M. 2017. Influenza A virus PA antagonizes interferon-β by interacting with interferon regulatory factor 3. Frontiers in Immunology, 8, 1051.

Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunological Reviews, 227, 54–65.